<DOC>
	<DOC>NCT02745678</DOC>
	<brief_summary>The purpose of this study is to investigate a novel thermosensitive topical gel formulation for the treatment of inflammatory bowel disease (IBD), specifically ulcerative colitis.</brief_summary>
	<brief_title>Localized Therapeutics for the Treatment of Gastrointestinal Disorders II</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Coal Tar</mesh_term>
	<criteria>Voluntarily sign written informed consent. Male or nonpregnant and nonlactating females at least 8 years of age. Confirmed diagnosis of active, mild to moderate ulcerative proctitis or proctosigmoiditis extending no further than 40cm from the anal verge. Typically, baseline Mayo Disease Activity Index (MMDAI) score between 5 and 10 (indicating mild to moderate disease). Known infection with Clostridium difficile (C. difficile) and/or other enteric pathogens 5aminosalicylic acid (5ASA) intolerance Current or recent (3 weeks) oral or rectal steroids History of thiopurine or Antitumor necrosis factor (AntiTNF) alpha treatment for colitis Abnormal creatinine Previous small bowel or colonic resection, Anal sphincter incompetence, Current smokers. History or current diagnosis of Crohn's disease or indeterminate colitis. History of diverticulitis, collagenous colitis, celiac disease, recurrent pancreatic or known gallbladder disease. Unstable significant cardiovascular, endocrine, neurologic or pulmonary disease. Hemoglobin levels &lt; 7.5 g/dL. History of sclerosing cholangitis, cirrhosis, or hepatic impairment Pregnant or at risk of pregnancy. Some medications to treat UC are prohibited during participation in the study, including laxatives and antidiarrhea medications; oral 5ASA agents and daily fiber supplements are allowed.</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Enema</keyword>
	<keyword>Ulcerative Colitis</keyword>
</DOC>